Diffusion tensor imaging in MDMA users and controls: Association with decision making

American Journal of Drug and Alcohol Abuse

Volumn 33, Issue 6, 2007, Pages 777-789

  Moeller, F Gerard ^a   Steinberg, Joel L ^a   Lane, Scott D ^a   Buzby, Matthew ^a   Swann, Alan C ^a   Hasan, Khader M ^b   Kramer, Larry A ^b   Narayana, Ponnada A ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Brain imaging; Corpus callosum; Diffusion tensor imaging; Eigenvalues; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ANISOTROPY; ARTICLE; BARRATT IMPULSIVENESS SCALE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DECISION MAKING; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; IOWA GAMBLING TASK; MALE; NEUROIMAGING; RATING SCALE; SCORING SYSTEM;

ADULT; AMPHETAMINE-RELATED DISORDERS; ANISOTROPY; CORPUS CALLOSUM; DECISION MAKING; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GAMBLING; HALLUCINOGENS; HUMANS; IMPULSIVE BEHAVIOR; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS;

EID: 36248985151     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990701651564     Document Type: Article

References (31)

1. Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E, Wilson MA. Neurotoxicity of MDMA and related compounds: Anatomic studies. Ann NY Acad Sci 1990; 600:649-661.
2. Baumann MH, Wang X, Rothman RB. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: A reappraisal of past and present findings. Psychopharmacology (Berl). 2007 Jan; 189(4):407-424.
3. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: Quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 1987; 242(3):911-916.
4. Chang L, Ernst T, Grob CS, Poland RE. Cerebral (1)H MRS alterations in recreational 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users. J Magn Reson Imaging 1999; 10(4):521-526.
5. Reneman L, Majoie CB, Flick H, den Heeten GJ. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: Preliminary results. AJNR Am J Neuroradiol 2002; 23(2):231-237.
6. Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J, Haga E, Vimal RL, Lukas SE, Renshaw PF. Reduced cortical gray matter density in human MDMA (Ecstasy) users: A voxel-based morphometry study. Drug Alcohol Depend 2003; 72(3):225-235.
7. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4(6):469-480.
8. Wozniak JR, Lim KO. Advances in white matter imaging: A review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci Biobehav Rev 2006; 30(6):762-774.
9. Hasan KM, Narayana PA. Retrospective measurement of the diffusion tensor eigenvalues from diffusion anisotropy and mean diffusivity in DTI. Magnetic Resonance in Medicine 2006; 56(1):130-137.
10. Gulani V, Webb AG, Duncan ID, Lauterbur PC (2001). Apparent diffusion tensor measurements in myelin-deficient rat spinal cords. Magn Reson Med. 2001; 45(2):191-195.
11. Pharmacol Rev 55(3):463-508.
12. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003; 20(3):1714-1722.
13. de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W (2006). A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology. 2007 Feb; 32(2):458-470.
14. First MB, Spitzer RL, Gibbon M, and Williams JB. Structured. Clinical Interview for DSM-IV Axis I Disorders Patient Edition. New York: Biometrics Research Department, New York State Psychiatric Institute 2006.
15. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9(3):199-213.
16. Moeller FG, Hasan KM, Steinberg JL, Kramer LA, Dougherty DM, Santos RM, Valdes I, Swann AC, Barratt ES, Narayana PA. Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine dependent subjects: diffusion tensor imaging. Neuropsychopharmacology 2005; 30(3):610-617.
17. Hasan KM, Parker DL, Alexander AL. Comparison of optimization procedures for diffusion-tensor encoding directions. JMRI 2001; 13:769-780.
18. Witelson SF. Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. Brain 1989; 112(Pt 3): 799-835.
19. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychology 1995; 51:768-774.
20. Allen TJ, Moeller FG, Rhoades HM, Cherek DR. Impulsivity and history of drug dependence. Drug Alcohol Depend 1998; 50:137-145.
21. Fingeret MC, Moeller FG, Stotts A. Gender differences among MDMA users on psychological and drug history variables. Addictive Disorders & Their Treatment 2005; 4(2):43-48.
22. Bechara A, Damasio AR, Damasio H, Tranel D, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50:7-15.
23. Bechara A, Damasio H, Tranel D, Damasio AR. Deciding advantageously before knowing the advantageous strategy. Science 1997; 276:1293-1295.
24. Bechara A, Damasio H, Tranel D, Anderson SW. Dissociation of working memory from decision making within the human prefrontal cortex. J Neurosci 1998; 18:428-437.
25. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 2001; 39(4):376-389.
26. Mori S, Wakana S, Nagae-Poetscher LM, van Zijl PCM. MRI Atlas of Human White Matter. Amsterdam: Elsevier, 2005.
27. Moeller FG, Steinberg JL, Dougherty DM, Narayana PA, Kramer LA, Renshaw PF. Functional MRI study of working memory in MDMA users. Psychopharmacology 2004; 177(1-2):185-194.
28. Gamma A, Buck A, Berthold T, Liechti ME, Vollenweider FX. 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans. Neuropsychopharmacology 2000 Oct; 23(4):388-395. Erratum in: Neuropsychopharmacology 2000 Nov; 23(5): following 598. Hell, D.
29. Quednow BB, Kuhn KU, Hoppe C, Westheide J, Maier W, Daum I, Wagner M. Elevated impulsivity and imparied decision-making cognition in heavy users of MDMA ("Ecstasy"). Psychopharmacology (Berl) 2005; 189(4):517-530.
30. Ramaekers JG, Kuypers KP. Acute effects of 3,4- Methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: Alone and in combination with alcohol. Neuropsychopharmacology 2006; 31(5):1048-1055.
31. Pfefferbaum A, Rosenbloom MJ, Adalsteinsson E, Sullivan EV (2006). Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: Synergistic white matter damage. Brain. 2007 Jan; 130(Pt 1):48-64.